ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

CERE Cerevel Therapeutics Holdings Inc

42,685
-0,025 (-0,06%)
Zuletzt aktualisiert: 21:57:28
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cerevel Therapeutics Holdings Inc CERE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,025 -0,06% 42,685 21:57:28
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
42,73 42,60 42,86 42,71
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202412:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
27.2.202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16.2.202422:46EDGAR2Form 8-K - Current report
09.2.202415:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09.2.202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202414:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
23.1.202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202413:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
18.1.202413:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
05.1.202423:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
03.1.202400:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
28.12.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202323:03EDGAR2Form 144 - Report of proposed sale of securities
22.12.202302:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202300:34EDGAR2Form 144 - Report of proposed sale of securities
11.12.202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08.12.202312:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
08.12.202301:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202322:32EDGAR2Form 144 - Report of proposed sale of securities
07.12.202322:31EDGAR2Form 144 - Report of proposed sale of securities
07.12.202314:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07.12.202314:00EDGAR2Form 8-K - Current report
07.12.202312:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
07.12.202305:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
06.12.202322:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
06.12.202300:42EDGAR2Form 144 - Report of proposed sale of securities
29.11.202312:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
08.11.202312:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
01.11.202311:39EDGAR2Form 8-K - Current report
01.11.202311:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
18.10.202322:32EDGAR2Form SC 13D/A - General statement of acquisition of..
13.10.202312:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
12.10.202322:19EDGAR2Form 8-K - Current report
12.10.202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12.10.202304:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
11.10.202322:14EDGAR2Form 8-K - Current report
11.10.202322:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11.10.202322:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock